chronic rhino sinusitis. js32.9
Conditions
Interventions
Intervention 1: Intervention group: receive one Puff of Furzemide spray (20 micrograms per puff equivalent to 40 micrograms) in each nasal side daily from one week before surgery. Intervention 2: Cont
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with chronic rhinosinusitis with or without polyposis (primary or recurrent) Ages between 18 and 60 years Normalization of PT, PTT, INR, BT, CT and platelet count
Exclusion criteria
Exclusion criteria: have Bleeding disorders such as uncontrolled hemophilia Uncontrolled history of thromboembolic events Uncontrolled Receive heparin at 48 hours before surgery ake aspirin within 3 days before surgery Allergies to Furesemaide Liver Cirrhosis Systemic diseases such as hypertension, diabetes, heart failure Patients with sinonasal tumor side effects of Furesemaide acute or chronic renal failure Cardiac stent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduce bleeding in surgery site. Timepoint: end of surgery time. Method of measurement: The amount of blood collected in the suction bottle (after deduction of normal saline volume) and the weight of blood-stained packs. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of vision of the surgical field. Timepoint: during the surgery. Method of measurement: with Boezaart Grading questionair. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbass Moradi
Hamedan University of Medical Sciences
Outcome results
None listed